AmbioPharm - A Global Peptide CDMO Email Format

Pharmaceutical ManufacturingSouth Carolina, United States51-200 Employees

AmbioPharm operates as a global contract development and manufacturing organization (CDMO) focused on custom synthetic peptide APIs for clinical and commercial use. The company maintains manufacturing facilities in South Carolina, USA and Shanghai, China, where it produces New Chemical Entities under cGMP for clients worldwide. Both facilities have been inspected by the FDA and other global regulators with excellent outcomes. Founded in 2005, AmbioPharm is headquartered in South Carolina and employs 51-200 people. In May 2026, CordenPharma International acquired AmbioPharm, reflecting a change in ownership and an expansion of peptide API capacity. The company is located at 1024 Dittman Court, Clearwater, South Carolina 29842, United States.

Get verified AmbioPharm - A Global Peptide CDMO emails free

Company overview Employee directory